Prostate cancer drug may be useful for preventionBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7405.9-a (Published 03 July 2003) Cite this as: BMJ 2003;327:9
- Janice Hopkins Tanne
- New York
The American Cancer Society and the National Cancer Institute have hailed the trial of a drug for prostate cancer as a milestone for cancer prevention, although the treatment can increase the aggressiveness of the cancer in some cases. And some commentators have questioned its use as a preventive, given the trial results.
Finasteride (Proscar), which is manufactured by Merck, reduced the incidence of prostate cancer by nearly 25% in a large, randomised, controlled trial and reduced symptoms of benign prostatic hypertrophy.
But prostate cancers that developed during the course …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial